Authors:
HIDDEMANN W
SCHLEYER E
UNTERHALT M
KERN W
BUCHNER T
Citation: W. Hiddemann et al., OPTIMIZING THERAPY FOR ACUTE MYELOID-LEUKEMIA BASED ON DIFFERENCES ININTRACELLULAR METABOLISM OF CYTOSINE-ARABINOSIDE BETWEEN LEUKEMIC BLASTS AND NORMAL MONONUCLEAR BLOOD-CELLS, Therapeutic drug monitoring, 18(4), 1996, pp. 341-349
Citation: H. Gerding et al., DIRECT NONINVASIVE MEASUREMENT OF TEAR OXYGEN-TENSION BENEATH GAS-PERMEABLE CONTACT-LENSES IN RABBITS, Investigative ophthalmology & visual science, 37(10), 1996, pp. 1935-1936
Authors:
MULLER C
KREMERSKOTHEN J
ZUHLSDORF M
CASSENS U
BUCHNER T
BARNEKOW A
KOCH OM
Citation: C. Muller et al., RAPID QUANTITATIVE-ANALYSIS OF PROTEIN-TYROSINE RESIDUE PHOSPHORYLATION IN DEFINED CELL-POPULATIONS IN WHOLE-BLOOD AND BONE-MARROW ASPIRATES, British Journal of Haematology, 94(3), 1996, pp. 461-463
Authors:
SCHOCH C
HAASE D
HAFERLACH T
FREUND M
LINK H
LENGFELDER E
LOFFLER H
BUCHNER T
FONATSCH C
Citation: C. Schoch et al., INCIDENCE AND IMPLICATION OF ADDITIONAL CHROMOSOME-ABERRATIONS IN ACUTE PROMYELOCYTIC LEUKEMIA WITH TRANSLOCATION T(15-17)(Q22-Q21) - A REPORT ON 50 PATIENTS, British Journal of Haematology, 94(3), 1996, pp. 493-500
Authors:
BUCHNER T
HIDDEMANN W
WORMANN B
LOFFLER H
GASSMANN W
HAFERLACH T
HEYLL A
AUL T
LENGFELDER E
MASCHMEYER G
LUDWIG WD
SAUERLAND MC
HEINECKE A
Citation: T. Buchner et al., INTENSIVE CONSOLIDATION VERSUS PROLONGED MAINTENANCE FOLLOWING INTENSIVE INDUCTION AND CONVENTIONAL CONSOLIDATION IN PRIMARY AML - A STUDY BY AMLCG, Blood, 88(10), 1996, pp. 846-846
Citation: M. Zuhlsdorf et al., PRIMARY ARA-C RESISTANCE OF AML PROGENITOR CELLS - IN-VITRO ASSAY VALIDATED BY CLINICAL-RESULTS, Blood, 88(10), 1996, pp. 1434-1434
Authors:
GRIESINGER F
PIRONOACK M
FALK M
KALB N
PUSCHEL M
TROFF C
GROVE D
BUCHNER T
RITTER J
HIDDEMANN W
WORMANN B
Citation: F. Griesinger et al., HIGH PREDICTIVE VALUE FOR RELAPSE BY 3-COLOR-FLOW-CYTROMETRIC DETECTION OF LEUKEMIA-ASSOCIATED IMMUNOPHENOTYPE (LAIP) POSITIVE CELLS IN ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), Blood, 88(10), 1996, pp. 1901-1901
Authors:
JAHNSSTREUBEL G
HAASE D
SCHOCH C
WORMANN B
BUCHNER T
FONATSCH C
HIDDEMANN W
Citation: G. Jahnsstreubel et al., CYTOGENETIC SUBGROUPS OF ACUTE MYELOID-LEUKEMIA (AML) DIFFER SIGNIFICANTLY IN PROLIFERATIVE ACTIVITY - CYTOKINE PRODUCTION AND SENSITIVITY TO GM-CSF STIMULATION, Blood, 88(10), 1996, pp. 2229-2229
Authors:
SCHOCH C
HAASE D
FONATSCH C
HAFERLACH T
SCHLEGELBERGER B
HOSSFELD DK
BECHER R
SAUERLAND MC
WORMANN B
HIDDEMANN W
BUCHNER T
Citation: C. Schoch et al., THE PROGNOSTIC IMPACT OF TRISOMY-8 IN ACUTE MYELOID-LEUKEMIA - COULD INTERPHASE CYTOGENETICS PROVIDE SUFFICIENT INFORMATION, Blood, 88(10), 1996, pp. 2234-2234
Authors:
HOELZER D
LUDWIG WD
THIEL E
GASSMANN W
LOFFLER H
FONATSCH C
RIEDER H
HEIL G
HEINZE B
ARNOLD R
HOSSFELD D
BUCHNER T
KOCH P
FREUND M
HIDDEMANN W
MASCHMEYER G
HEYLL A
AUL C
FAAK T
KUSE R
ITTEL TH
GRAMATZKI M
DIEDRICH H
KOLBE K
FUHR HG
FISCHER K
SCHADECKGRESSEL C
WEISS A
STROHSCHEER I
METZNER B
FABRY U
GOKBUGET N
VOLKERS B
MESSERER D
UBERLA K
Citation: D. Hoelzer et al., IMPROVED OUTCOME IN ADULT B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 87(2), 1996, pp. 495-508
Authors:
SPERLING C
BUCHNER T
CREUTZIG U
RITTER J
HARBOTT J
FONATSCH C
SAUERLAND C
MIELCAREK M
MASCHMEYER G
LOFFLER H
LUDWIG WD
Citation: C. Sperling et al., CLINICAL, MORPHOLOGIC, CYTOGENETIC AND PROGNOSTIC IMPLICATIONS OF CD34 EXPRESSION IN CHILDHOOD AND ADULT DE-NOVO AML, Leukemia & lymphoma, 17(5-6), 1995, pp. 417-426
Citation: W. Hiddemann et T. Buchner, RATIONALE FOR HIGH-DOSE CHEMOTHERAPY AND APPLICATION OF HEMATOPOIETICGROWTH-FACTORS IN ACUTE MYELOID-LEUKEMIA, Annals of oncology, 6, 1995, pp. 27-31
Authors:
VONEIFF M
ZUHLSDORF M
ROOS N
THOMAS M
BUCHNER T
VANDELOO J
Citation: M. Voneiff et al., PULMONARY-INFILTRATES IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES - CLINICAL USEFULNESS OF NONINVASIVE BRONCHOSCOPIC PROCEDURES, European journal of haematology, 54(3), 1995, pp. 157-162
Authors:
JAHNSSTREUBEL G
REUTER C
UNTERHALT M
SCHLEYER E
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: G. Jahnsstreubel et al., BLAST CELL PROLIFERATIVE ACTIVITY AND SENSITIVITY TO CM-CSF IN-VITRO ARE ASSOCIATED WITH EARLY RESPONSE TO TAD-9 INDUCTION THERAPY IN ACUTEMYELOID-LEUKEMIA, Leukemia, 9(11), 1995, pp. 1857-1863
Authors:
JAHNSSTREUBEL G
REUTER C
UNTERHALT M
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: G. Jahnsstreubel et al., BLAST CELL PROLIFERATIVE ACTIVITY AND SENSITIVITY TO GM-CSF IN THE CONTEXT OF CULTURE CONDITIONS AND AUTONOMOUS GROWTH-FACTOR PRODUCTION INACUTE MYELOID-LEUKEMIA (AML), Experimental hematology, 23(8), 1995, pp. 933-933
Authors:
SPERLING C
SCHWARTZ S
MAURER J
HEINECKE A
BUCHNER T
ZIMMERMANN M
CREUTZIG U
BUHRING HJ
SCHOCH C
FONATSCH C
LOFFLER H
HOELZER D
THIEL E
HERRMANN F
LUDWIG WD
Citation: C. Sperling et al., CD117 EXPRESSION IS RESTRICTED TO MYELOID AND EARLY T-LINEAGE DIFFERENTIATION IN ACUTE-LEUKEMIA AND LACKS PROGNOSTIC-SIGNIFICANCE IN AML, Blood, 86(10), 1995, pp. 147-147
Authors:
SCHOCH C
HAASE D
HAFERLACH T
BUCHNER T
FREUND M
LINK H
LOFFLER H
FONATSCH C
Citation: C. Schoch et al., SECONDARY CHROMOSOME-ABERRATIONS IN ACUTE MYELOID-LEUKEMIA WITH T(8-21)(Q22-Q22), INV(16)(P13Q22) OR T(15-17)(Q22-Q21), Blood, 86(10), 1995, pp. 160-160
Authors:
HAFERLACH T
LOFFLER H
GASSMANN W
SCHOCH R
FONATSCH C
SCHOCH C
SCHLEGELBERGER B
LUDWIG WD
THIEL E
BECHER R
HEINECKE A
SAUERLAND MC
BUCHNER T
Citation: T. Haferlach et al., TRILINEAGE DYSPLASIA (TLD) IS CORRELATED WITH A BAD PROGNOSIS IN DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) - FIRST RESULTS OF A PROSPECTIVE-STUDY FROM THE GERMAN AMLCG-TRIAL, Blood, 86(10), 1995, pp. 165-165
Authors:
GAHN B
HAASE D
UNTERHALT M
DRESCHER M
SCHOCH C
FONATSCH C
TERSTAPPEN LWMM
HIDDEMANN W
BUCHNER T
WORMANN B
BENNETT JM
Citation: B. Gahn et al., DE-NOVO AML WITH DYSPLASTIC HEMATOPOIESIS - CORRELATION WITH CYTOGENETIC ABNORMALITIES AND PROGNOSIS, Blood, 86(10), 1995, pp. 166-166
Authors:
HIDDEMANN W
FONATSCH C
WORMANN B
HEINECKE A
SAUERLAND C
SCHARNHORST S
BUCHNER T
Citation: W. Hiddemann et al., CYTOGENETIC SUBGROUPS OF AML AND OUTCOME FROM HIGH-DOSE VERSUS CONVENTIONAL-DOSE ARA-C AS PART OF DOUBLE INDUCTION THERAPY, Blood, 86(10), 1995, pp. 1054-1054